Preclinical evidence of rapid-onset antidepressant-like effect in radix polygalae extract

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Shin, Im Joon ^a   Son, Sung Un ^a   Park, Hyunwoo ^a   Kim, Yoorim ^a   Park, Sung Hyun ^a   Swanberg, Kelley ^a   Shin, Joo Yeon ^a   Ha, Sang Kyu ^a   Cho, Yoonju ^a   Bang, Soo Yong ^a   Lew, Jae Hwan ^a   Cho, Seung Hun ^a   Maeng, Sungho ^a  

^a Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; GLUTAMATE RECEPTOR 1; KETAMINE; MAMMALIAN TARGET OF RAPAMYCIN; PLANT EXTRACT; POLYGALA RADIX EXTRACT; SACCHARIN; SERINE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ANXIETY; ARTICLE; C57BL 6 MOUSE; CHRONIC STRESS; CONTROLLED STUDY; FORCED SWIM TEST; HIPPOCAMPUS; HOPELESSNESS; IMMOBILITY; LATENT PERIOD; MALE; MOUSE; NONHUMAN; POLYGALA; PROTEIN PHOSPHORYLATION; SNIFFING; TAIL SUSPENSION TEST;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; CHRONIC DISEASE; DEPRESSION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; FEMALE; GLUTAMATES; HIPPOCAMPUS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; PHOSPHORYLATION; PHYTOTHERAPY; PLANT EXTRACTS; PROTEIN SUBUNITS; RECEPTORS, AMPA; STRESS, PSYCHOLOGICAL; SYNAPSES; TIME FACTORS; TOR SERINE-THREONINE KINASES;

EID: 84895744868     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088617     Document Type: Article

References (68)

1. Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, et al. (2013) Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med 10: e1001547.
2. Wilkinson P, Izmeth Z (2012) Continuation and maintenance treatments for depression in older people. Cochrane Database Syst Rev 11: CD006727.
3. Keith SJ, Matthews SM (1993) The value of psychiatric treatment: its efficacy in severe mental disorders. Psychopharmacol Bull 29: 427-430. (Pubitemid 24206387)
4. Jick H, Kaye JA, Jick SS (2004) Antidepressants and the risk of suicidal behaviors. Jama 292: 338-343. (Pubitemid 38944257)
5. Gibbons RD, Brown CH, Hur K, Davis JM, Mann JJ (2012) Suicidal Thoughts and Behavior With Antidepressant Treatment: Reanalysis of the Randomized Placebo-Controlled Studies of Fluoxetine and Venlafaxine. Arch Gen Psychiatry.
6. Maeng S, Zarate CA, Jr. (2007) The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects. Curr Psychiatry Rep 9: 467-474. (Pubitemid 350284937)
7. Auer DP, Putz B, Kraft E, Lipinski B, Schill J, et al. (2000) Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 47: 305-313. (Pubitemid 30109243)
8. Papp M, Moryl E (1996) Antidepressant-like effects of 1-aminocyclopropanecarboxylic acid and D-cycloserine in an animal model of depression. Eur J Pharmacol 316: 145-151. (Pubitemid 27008144)
9. Moryl E, Danysz W, Quack G (1993) Potential antidepressive properties of amantadine, memantine and bifemelane. Pharmacol Toxicol 72: 394-397. (Pubitemid 23188507)
10. Calabrese JR, Suppes T, Bowden CL, Sachs GS, Swann AC, et al. (2000) A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapidcycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry 61: 841-850.
11. Gourley SL, Espitia JW, Sanacora G, Taylor JR (2012) Antidepressant-like properties of oral riluzole and utility of incentive disengagement models of depression in mice. Psychopharmacology (Berl) 219: 805-814.
12. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, et al. (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47: 351-354. (Pubitemid 30109248)
13. Zarate CA, Jr., Singh JB, Carlson PJ, Brutsche NE, Ameli R, et al. (2006) A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63: 856-864. (Pubitemid 44188478)
14. Maeng S, Zarate CA, Jr., Du J, Schloesser RJ, McCammon J, et al. (2008) Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry 63: 349-352. (Pubitemid 351146651)
15. Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, et al. (2010) mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329: 959-964.
16. Farber NB (2003) The NMDA receptor hypofunction model of psychosis. Ann N Y Acad Sci 1003: 119-130.
17. Chung IW, Kim SR, Kim EG (1992) Dopamine-2 and serotonin-2 receptor bindings in antipsychotic medicines from natural products. J Kor Neuropsychiatr Assoc 31: 856-867.
18. Chang HM, But PPH (1986) Pharmacology and applications of chinese material medica. Singapore: World Scientific Publishing. 551-553 p.
19. Cheng MC, Li CY, Ko HC, Ko FN, Lin YL, et al. (2006) Antidepressant principles of the roots of Polygala tenuifolia. J Nat Prod 69: 1305-1309.
20. Lee JY, Park JH, Kim KR, Kim TH, Kang HW, et al. (2004) Protective Effects of Radix Polygalae on Dopamine-induced Cell Death in Human SH-SY5Y Dopaminergic Neuroblastoma Cells. Korean journal of Oriental Physiology and Pathology 18: 544-552.
21. Lee SB, Sung NS, Lee YJ (2005) A Study on the Protective Effects of Polygalae Radix on Neurotoxicity Induced by N-methyl-D-aspartic acid(NMDA). Korean Journal of Herbalogy 20: 115-125.
22. Hu Y, Liu P, Guo DH, Rahman K, Wang DX, et al. (2010) Antidepressant effects of the extract YZ-50 from Polygala tenuifolia in chronic mild stress treated rats and its possible mechanisms. Pharm Biol 48: 794-800.
23. Liu P, Hu Y, Guo DH, Wang DX, Tu HH, et al. (2010) Potential antidepressant properties of Radix Polygalae (Yuan Zhi). Phytomedicine 17: 794-799.
24. Sun XL, Ito H, Masuoka T, Kamei C, Hatano T (2007) Effect of Polygala tenuifolia root extract on scopolamine-induced impairment of rat spatial cognition in an eight-arm radial maze task. Biol Pharm Bull 30: 1727-1731. (Pubitemid 47403253)
25. Lee HJ, Ban JY, Koh SB, Seong NS, Song KS, et al. (2004) Polygalae radix extract protects cultured rat granule cells against damage induced by NMDA. Am J Chin Med 32: 599-610. (Pubitemid 39302677)
26. Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 85: 367-370. (Pubitemid 15123115)
27. Borsini F, Meli A (1988) Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology (Berl) 94: 147-160. (Pubitemid 18040687)
28. Malkesman O, Scattoni ML, Paredes D, Tragon T, Pearson B, et al. (2010) The female urine sniffing test: a novel approach for assessing reward-seeking behavior in rodents. Biol Psychiatry 67: 864-871.
29. Dulawa SC, Hen R (2005) Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test. Neurosci Biobehav Rev 29: 771-783. (Pubitemid 40762599)
30. Garcia-Gutierrez MS, Perez-Ortiz JM, Gutierrez-Adan A, Manzanares J (2010) Depression-resistant endophenotype in mice overexpressing cannabinoid CB(2) receptors. Br J Pharmacol 160: 1773-1784.
31. Pryce CR, Azzinnari D, Spinelli S, Seifritz E, Tegethoff M, et al. (2011) Helplessness: a systematic translational review of theory and evidence for its relevance to understanding and treating depression. Pharmacol Ther 132: 242-267.
32. Hogg S (1996) A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav 54: 21-30.
33. Nestler EJ, Hyman SE (2010) Animal models of neuropsychiatric disorders. Nat Neurosci 13: 1161-1169.
34. Sui ZY, Chae HJ, Huang GB, Zhao T, Shrestha Muna S, et al. (2012) Effects of chronic mild stress in female bax inhibitor-1-gene knockout mice. Clin Psychopharmacol Neurosci 10: 155-162.
35. Bai F, Li X, Clay M, Lindstrom T, Skolnick P (2001) Intra- and interstrain differences in models of ''behavioral despair''. Pharmacol Biochem Behav 70: 187-192. (Pubitemid 33049928)
36. Cryan JF, Mombereau C, Vassout A (2005) The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 29: 571-625. (Pubitemid 40755457)
37. Corssen G (1969) Dissociative anesthesia with ketamine hydrochloride. Proc Inst Med Chic 27: 341-342.
38. Bettio LE, Cunha MP, Budni J, Pazini FL, Oliveira A, et al. (2012) Guanosine produces an antidepressant-like effect through the modulation of NMDA receptors, nitric oxide-cGMP and PI3K/mTOR pathways. Behav Brain Res.
39. Der-Avakian A, Markou A (2012) The neurobiology of anhedonia and other reward-related deficits. Trends Neurosci 35: 68-77.
40. Cryan JF, Markou A, Lucki I (2002) Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 23: 238-245. (Pubitemid 34465544)
41. Willner P, Moreau JL, Nielsen CK, Papp M, Sluzewska A (1996) Decreased hedonic responsiveness following chronic mild stress is not secondary to loss of body weight. Physiol Behav 60: 129-134. (Pubitemid 126335862)
42. Matthews K, Forbes N, Reid IC (1995) Sucrose consumption as an hedonic measure following chronic unpredictable mild stress. Physiol Behav 57: 241-248.
43. Hu Y, Liao HB, Liu P, Guo DH, Rahman K (2009) A bioactive compound from Polygala tenuifolia regulates efficiency of chronic stress on hypothalamic-pituitary-adrenal axis. Pharmazie 64: 605-608.
44. Sun Y, Xie TT, Wang DX, Liu P (2009) [Effect of Polygala tenuifolia Willd YZ- 50 on the mRNA expression of brain-derived neurotrophic factor and its receptor TrkB in rats with chronic stress depression]. Nan Fang Yi Ke Da Xue Xue Bao 29: 1199-1203.
45. Xie W, Yang Y, Gu X, Zheng Y, Sun YE, et al. (2012) Senegenin attenuates hepatic ischemia-reperfusion induced cognitive dysfunction by increasing hippocampal NR2B expression in rats. PLoS One 7: e45575.
46. Burgdorf J, Zhang XL, Nicholson KL, Balster RL, Leander JD, et al. (2013) GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects. Neuropsychopharmacology 38: 729-742.
47. Shimazaki T, Kaku A, Chaki S (2007) Blockade of the metabotropic glutamate 2/3 receptors enhances social memory via the AMPA receptor in rats. Eur J Pharmacol 575: 94-97. (Pubitemid 47576076)
48. Bradley SR, Uslaner JM, Flick RB, Lee A, Groover KM, et al. (2012) The mGluR7 allosteric agonist AMN082 produces antidepressant-like effects by modulating glutamatergic signaling. Pharmacol Biochem Behav 101: 35-40.
49. Yang C, Li WY, Yu HY, Gao ZQ, Liu XL, et al. (2012) Tramadol pretreatment enhances ketamine-induced antidepressant effects and increases mammalian target of rapamycin in rat hippocampus and prefrontal cortex. J Biomed Biotechnol 2012: 175619.
50. Denk MC, Rewerts C, Holsboer F, Erhardt-Lehmann A, Turck CW (2011) Monitoring ketamine treatment response in a depressed patient via peripheral mammalian target of rapamycin activation. Am J Psychiatry 168: 751-752.
51. Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, et al. (2012) NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 475: 91-95.
52. Lee HK, Takamiya K, Han JS, Man H, Kim CH, et al. (2003) Phosphorylation of the AMPA receptor GluR1 subunit is required for synaptic plasticity and retention of spatial memory. Cell 112: 631-643. (Pubitemid 36331776)
53. Ehlers MD (2000) Reinsertion or degradation of AMPA receptors determined by activity-dependent endocytic sorting. Neuron 28: 511-525.
54. Ibrahim L, Diaz Granados N, Jolkovsky L, Brutsche N, Luckenbaugh DA, et al. (2012) A Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorder. J Clin Psychopharmacol 32: 551-557.
55. Black MD (2005) Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data. Psychopharmacology (Berl) 179: 154-163.
56. Bleakman D, Lodge D (1998) Neuropharmacology of AMPA and kainate receptors. Neuropharmacology 37: 1187-1204. (Pubitemid 28511275)
57. Palucha A, Pilc A (2007) Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs. Pharmacol Ther 115: 116-147. (Pubitemid 46992810)
58. Sanacora G, Kendell SF, Levin Y, Simen AA, Fenton LR, et al. (2007) Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms. Biol Psychiatry 61: 822-825. (Pubitemid 46330247)
59. Zarate CA, Jr., Payne JL, Quiroz J, Sporn J, Denicoff KK, et al. (2004) An open-label trial of riluzole in patients with treatment-resistant major depression. Am J Psychiatry 161: 171-174. (Pubitemid 38419327)
60. Palucha-Poniewiera A, Wieronska JM, Branski P, Stachowicz K, Chaki S, et al. (2010) On the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039. Psychopharmacology (Berl) 212: 523-535.
61. Dwyer JM, Lepack AE, Duman RS (2012) mTOR activation is required for the antidepressant effects of mGluR(2)/(3) blockade. Int J Neuropsychopharmacol 15: 429-434.
62. Pomierny-Chamiolo L, Poleszak E, Pilc A, Nowak G (2010) NMDA but not AMPA glutamatergic receptors are involved in the antidepressant-like activity of MTEP during the forced swim test in mice. Pharmacol Rep 62: 1186-1190.
63. Chen Y, Huang X, Chen W, Wang N, Li L (2012) Tenuigenin promotes proliferation and differentiation of hippocampal neural stem cells. Neurochem Res 37: 771-777.
64. Chen YJ, Huang XB, Li ZX, Yin LL, Chen WQ, et al. (2010) Tenuigenin protects cultured hippocampal neurons against methylglyoxal-induced neurotoxicity. Eur J Pharmacol 645: 1-8.
65. Lv J, Jia H, Jiang Y, Ruan Y, Liu Z, et al. (2009) Tenuifolin, an extract derived from tenuigenin, inhibits amyloid-beta secretion in vitro. Acta Physiol (Oxf) 196: 419-425.
66. Zhang H, Han T, Zhang L, Yu CH, Wan DG, et al. (2008) Effects of tenuifolin extracted from radix polygalae on learning and memory: a behavioral and biochemical study on aged and amnesic mice. Phytomedicine 15: 587-594.
67. Hu Y, Liao HB, Dai-Hong G, Liu P, Wang YY, et al. (2010) Antidepressant-like effects of 3,69-disinapoyl sucrose on hippocampal neuronal plasticity and neurotrophic signal pathway in chronically mild stressed rats. Neurochem Int 56: 461-465.
68. Kawashima K, Miyako D, Ishino Y, Makino T, Saito K, et al. (2004) Anti-stress effects of 3,4,5-trimethoxycinnamic acid, an active constituent of roots of Polygala tenuifolia (Onji). Biol Pharm Bull 27: 1317-1319. (Pubitemid 41701736)